Skip to content

Natera, Inc. NTRA Reportable Segment — Total revenues

Similar metrics at other companies

Open Text logo
OTEXReportable Segment — Total revenues
$1.28B+2.2%
Trinet Group logo
TNETReportable Segment — Total revenues
$1.23B-5.1%
RingCentral logo
RNGReportable Segment — Total revenues
$644.2M+5.3%
Calix logo
CALXReportable Segment — Total revenues
$279.98M+27.1%
ADT logo
ADTReportable Segment — Total Revenue
$1.28B+0.9%
Omnicell logo
OMCLReportable Segment — Total revenues
$309.88M+14.9%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$37.51B+59.8%
Enterprise value$36.66B+61.8%
P/S15×+3.1×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s reportable segment — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natera, Inc.'s reportable segment — total revenues?
Natera, Inc. (NTRA) reported reportable segment — total revenues of $696.64M in Q1 2026.
What does reportable segment — total revenues mean?
This metric represents the total revenue generated by a specific reportable business segment, reflecting the aggregate value of products and services sold within that division. It serves as a primary indicator of the segment's market scale and its contribution to the company's overall top-line performance. Monitoring this figure helps investors assess the growth trajectory and market adoption of the segment's specific diagnostic offerings.